dipyridamole has been researched along with Intermittent Claudication in 15 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Intermittent Claudication: A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "32 patients (mean age 65 years, range 51-75 years) were included in this controlled, double blind study to evaluate the effect of dipyridamole in patients with intermittent claudication." | 9.07 | [Double-blind study of the effect of dipyridamole in patients with intermittent claudication]. ( Baumgartner, I; Bollinger, A; Schalch, I, 1992) |
| "32 patients (mean age 65 years, range 51-75 years) were included in this controlled, double blind study to evaluate the effect of dipyridamole in patients with intermittent claudication." | 5.07 | [Double-blind study of the effect of dipyridamole in patients with intermittent claudication]. ( Baumgartner, I; Bollinger, A; Schalch, I, 1992) |
| " Moreover, patients without any history of coronary heart disease and showing a normal resting ECG underwent a bicycle exercise test or a dipyridamole thallium scintigraphy to detect possible silent myocardial ischemia." | 3.69 | Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. ( Brun, JM; Cohen, M; Gambert, P; Lagrost, L; Petit, JM; Vaillant, G; Vergès, BL, 1997) |
| "For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched June 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 5)." | 2.52 | Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. ( Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedenis, R | 1 |
| Lethaby, A | 1 |
| Maxwell, H | 1 |
| Acosta, S | 1 |
| Prins, MH | 1 |
| Dörffler-Melly, J | 1 |
| Schmidli, J | 1 |
| Mahler, F | 2 |
| Heidrich, H | 1 |
| Bollinger, A | 2 |
| Biland, L | 1 |
| Brunner, U | 1 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Schneider, E | 1 |
| Widmer, LK | 1 |
| Kohler, TR | 1 |
| Kaufman, JL | 1 |
| Kacoyanis, G | 1 |
| Clowes, A | 1 |
| Donaldson, MC | 1 |
| Kelly, E | 1 |
| Skillman, J | 1 |
| Couch, NP | 1 |
| Whittemore, AD | 1 |
| Mannick, JA | 1 |
| Heinrich, F | 1 |
| Verstraete, M | 1 |
| Rose, EL | 1 |
| Liu, XJ | 1 |
| Henley, M | 1 |
| Lewis, JD | 1 |
| Raftery, EB | 1 |
| Lahiri, A | 1 |
| Darbar, D | 1 |
| Gillespie, N | 1 |
| Main, G | 1 |
| Bridges, AB | 1 |
| Kennedy, NS | 1 |
| Pringle, TH | 1 |
| McNeill, GP | 1 |
| Vergès, BL | 1 |
| Lagrost, L | 1 |
| Vaillant, G | 1 |
| Petit, JM | 1 |
| Cohen, M | 1 |
| Gambert, P | 1 |
| Brun, JM | 1 |
| Baumgartner, I | 1 |
| Schalch, I | 1 |
| Mannarino, E | 1 |
| Pasqualini, L | 1 |
| Innocente, S | 1 |
| Scricciolo, V | 1 |
| Rignanese, A | 1 |
| Ciuffetti, G | 1 |
| Di Perri, T | 1 |
| Pasini, FL | 1 |
| Pecchi, S | 1 |
| De Franco, V | 1 |
| Damiani, P | 1 |
| Pasqui, AL | 1 |
| Capecchi, PL | 1 |
| Orrico, A | 1 |
| Materazzi, M | 1 |
| Domini, L | 1 |
| Libretti, A | 2 |
| Catalano, M | 2 |
2 reviews available for dipyridamole and Intermittent Claudication
| Article | Year |
|---|---|
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vas | 2015 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
6 trials available for dipyridamole and Intermittent Claudication
| Article | Year |
|---|---|
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Bl | 1982 |
Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease.
Topics: Aged; Cardiac Catheterization; Coronary Disease; Dipyridamole; Female; Follow-Up Studies; Humans; In | 1996 |
[Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
Topics: Aged; Dipyridamole; Double-Blind Method; Exercise Test; Female; Humans; Intermittent Claudication; I | 1992 |
Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined?
Topics: Aspirin; Combined Modality Therapy; Dipyridamole; Exercise Therapy; Female; Humans; Intermittent Cla | 1991 |
Treatment of claudication with dipyridamole and aspirin.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Com | 1986 |
Treatment of claudication with dipyridamole and aspirin.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combin | 1986 |
7 other studies available for dipyridamole and Intermittent Claudication
| Article | Year |
|---|---|
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl | 2003 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
Topics: Aged; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Female; Graft Survival; H | 1984 |
[Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Int | 1984 |
Prognostic value of noninvasive cardiac tests in the assessment of patients with peripheral vascular disease.
Topics: Aged; Cardiac Catheterization; Coronary Disease; Dipyridamole; Electrocardiography; Electrocardiogra | 1993 |
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Topics: Apolipoproteins A; Biomarkers; Blood Glucose; Blood Pressure; Cerebrovascular Disorders; Cholesterol | 1997 |
In vivo and in vitro evidence of an adenosine-mediated mechanism of calcium entry blocker activities.
Topics: Adenosine; Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Female; Flunarizine; | 1989 |